Five years had passed since the global rollout of Promethean, and the landscape of human medicine had been irrevocably transformed. In medical textbooks and public health annals, the decade was marked as the dawn of the *Post-Oncology Era*. Glioblastoma multiforme, once considered an automatic death sentence, had achieved an overall five-year survival rate of ninety-seven point six percent across ninety-four nations. Diffuse intrinsic pontine glioma in pediatric patients had been…
Keep reading in the app
This chapter is in the Booknovel app. Unlock it with coins, a short ad, the free timer or VIP.
Scan with your phone camera
Opens chapter 26 directly. New readers get free coins.
